Current Literature for Evidence-Based Infrainguinal Endovascular Treatment

Seminars in Vascular Surgery

Volumn 21, Issue 4, 2008, Pages 210-216

  Meier, George H ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CILOSTAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITINOL; PACLITAXEL; PENTOXIFYLLINE; RAPAMYCIN;

ARTERY DISEASE; ARTICLE; BARE METAL STENT; BYPASS SURGERY; CLAUDICATION; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DRUG ELUTING STENT; ENDOVASCULAR SURGERY; EVIDENCE BASED MEDICINE; HUMAN; LEG ISCHEMIA; LIMB ISCHEMIA; MEDICAL DECISION MAKING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REVASCULARIZATION; SUPERFICIAL FEMORAL ARTERY OCCLUSIVE DISEASE;

ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CONSTRICTION, PATHOLOGIC; DRUG-ELUTING STENTS; EVIDENCE-BASED MEDICINE; HUMANS; LOWER EXTREMITY; PATIENT SELECTION; STENTS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 57349189427     PISSN: 08957967     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semvascsurg.2008.11.008     Document Type: Article

References (49)

1. Spronk S., Bosch J.L., den Hoed P.T., Veen H.F., Pattynama P.M., and Hunink M.M. Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial. J Vasc Surg 6 (2008) Sep 3 [Epub ahead of print]
2. Whyman M.R., and Ruckley C.V. Should claudicants receive angioplasty or just exercise training?. Cardiovasc Surg 6 (1998) 226-231
3. Williams L.R., Ekers M.A., Collins P.S., and Lee J.F. Vascular rehabilitation: benefits of a structured exercise/risk modification program. J Vasc Surg 14 (1991) 320-326
4. Love KM, Stoner MC, deFreitas DJ, et al: An analysis of femoropopliteal bypass after failed endovascular therapy: are we burning bridges? Presented at the Society for Clinical Vascular Surgery, 2008, Las Vegas, NV, 2008
5. Cox G.S., Hertzer N.R., Young J.R., et al. Nonoperative treatment of superficial femoral artery disease: long-term follow-up. J Vasc Surg 17 (1993) 172-181
6. Hertzer N.R. The natural history of peripheral vascular disease. Implications for its management. Circulation 83 suppl (1991) I12-I19
7. Whyman M.R., Fowkes F.G., Kerracher E.M., et al. Is intermittent claudication improved by percutaneous transluminal angioplasty?. A randomized controlled trial. J Vasc Surg 26 (1997) 551-557
8. Whyman M.R., Fowkes F.G., Kerracher E.M., et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. Eur J Vasc Endovasc Surg 12 (1996) 167-172
9. Whyman M.R., Ruckley C.V., and Fowkes F.G. Angioplasty for mild intermittent claudication. Br J Surg 78 (1991) 643-645
10. Taylor S.M., Kalbaugh C.A., Healy M.G., et al. Do current outcomes justify more liberal use of revascularization for vasculogenic claudication?. A single center experience of 1,000 consecutively treated limbs. J Am Coll Surg 206 (2008) 1053-1062 discussion 1062-1064
11. Schouten O., van Waning V.H., Kertai M.D., et al. Perioperative and long-term cardiovascular outcomes in patients undergoing endovascular treatment compared with open vascular surgery for abdominal aortic aneurysm or iliaco-femoro-popliteal bypass. Am J Cardiol 96 (2005) 861-866
12. Kinikini D., Sarfati M.R., Mueller M.T., and Kraiss L.W. Amerian Heart Association; American College of Cardiology: Meeting AHA/ACC secondary prevention goals in a vascular surgery practice: an opportunity we cannot afford to miss. J Vasc Surg 43 (2006) 781-787
13. Mannava K., and Money S.R. Current management of peripheral arterial occlusive disease: a review of pharmacologic agents and other interventions. Am J Cardiovasc Drugs 7 (2007) 59-66
14. Cassar K., Ford I., Greaves M., Bachoo P., and Brittenden J. Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after lower limb angioplasty. Br J Surg 92 (2005) 159-165
15. Ferreira M., Lanziotti L., Monteiro M., et al. Superficial femoral artery recanalization with self-expanding nitinol stents: long-term follow-up results. Eur J Vasc Endovasc Surg 34 (2007) 702-708
16. Laird J.R. Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. J Endovasc Ther 13 suppl 2 (2006) II30-II40
17. Schlager O., Dick P., Sabeti S., et al. Long-segment SFA stenting-the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther 12 (2005) 676-684
18. O'Brien-Irr M.S., Harris L.M., Dosluoglu H.H., Dayton M., and Dryjski M.L. Lower extremity endovascular interventions: can we improve cost-efficiency?. J Vasc Surg 47 (2008) 982-987 discussion 987
19. Powell R.J., Fillinger M., Walsh D.B., Zwolak R., and Cronenwett J.L. Predicting outcome of angioplasty and selective stenting of multisegment iliac artery occlusive disease. J Vasc Surg 32 (2000) 564-569
20. Schillinger M., and Minar E. Endovascular stent implantation for treatment of peripheral artery disease. Eur J Clin Invest 37 (2007) 165-170
21. Schmieder G.C., Richards A.I., Scott E.C., Stokes G.K., Meier III G.H., and Panneton J.M. Selective stenting in subintimal angioplasty: analysis of primary stent outcomes. J Vasc Surg 48 (2008) 1175-1180 discussion 1180-1181
22. Heidland U.E., Heintzen M.P., Michel C.J., and Strauer B.E. Risk factors for the development of restenosis following stent implantation of venous bypass grafts. Heart 85 (2001) 312-317
23. Kastrati A., Schömig A., Dirschinger J., et al. Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation 101 (2000) 2478-2483
24. Aristides M., Gliksman M., Rajan N., and Davey P. Effectiveness and cost effectiveness of single bolus treatment with abciximab (Reo Pro) in preventing restenosis following percutaneous transluminal coronary angioplasty in high risk patients. Heart 79 (1998) 12-17
25. Ozbek C., Heisel A., Gross B., Bay W., and Schieffer H. Coronary implantation of silicone-carbide-coated Palmaz-Schatz stents in patients with high risk of stent thrombosis without oral anticoagulation. Cathet Cardiovasc Diagn 41 (1997) 71-78
26. Strauss B.H., Serruys P.W., de Scheerder I.K., et al. Relative risk analysis of angiographic predictors of restenosis within the coronary Wallstent. Circulation 84 (1991) 1636-1643
27. Duda S.H., Bosiers M., Lammer J., et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 13 (2006) 701-710
28. Wolfram R.M., Pokrajac B., Ahmadi R., et al. Endovascular brachytherapy for prophylaxis against restenosis after long-segment femoropopliteal placement of stents: initial results. Radiology 220 (2001) 724-729
29. Duda S.H., Pusich B., Richter G., et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 106 (2002) 1505-1509
30. Siablis D., Kamabatidis D., Katsanos K., et al. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit. J Endovasc Ther 14 (2007) 241-250
31. Siablis D., Kamabatidis D., Katsanos K., et al. Infrapopliteal application of paclitaxel-eluting stents for critical limb ischemia: midterm angiographic and clinical results. J Vasc Interv Radiol 18 (2007) 1351-1361
32. Adam D.J., Beard J.D., Cleveland T., et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366 9501 (2005) 1925-1934
33. Ansel G.M., Botti Jr. C.F., and Silver M.J. The use of femoropopliteal stent-grafts for critical limb ischemia. Tech Vasc Interv Radiol 8 (2005) 140-145
34. Desgranges P., Cron J., Allaire E., Becquemin J.P., and Melliere D. Late reoperations after surgical and endovascular lower limb revascularisation. Eur J Vasc Endovasc Surg 23 (2002) 44-48
35. Krajcer Z., and Diethrich E.B. Successful endoluminal repair of arterial aneurysms by Wallstent prosthesis and PTFE graft: preliminary results with a new technique. J Endovasc Surg 4 (1997) 80-87
36. Morrissey N.J. Endovascular treatment of peripheral arterial aneurysms. Mt Sinai J Med 71 (2004) 1-3
37. Sultan S., Esan O., and Fahy A. Nonoperative active management of critical limb ischemia: initial experience using a sequential compression biomechanical device for limb salvage. Vascular 16 (2008) 130-139
38. Varty K., London N.J., Ratliff D.A., Bell P.R., and Bolia A. Percutaneous angioplasty of the profunda femoris artery: a safe and effective endovascular technique. Eur J Vasc Surg 7 (1993) 483-487
39. Creasy T.S., McMillan P.J., Fletcher E.W., Collin J., and Morris P.J. Is percutaneous transluminal angioplasty better than exercise for claudication?. Preliminary results from a prospective randomised trial. Eur J Vasc Surg 4 (1990) 135-140
40. Perkins J.M., Collin J., Creasy T.S., Fletcher E.W., and Morris P.J. Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. Eur J Vasc Endovasc Surg 11 (1996) 409-413
41. Bachoo P., and Thorpe P. Endovascular stents for intermittent claudication. Cochrane Database Syst Rev (2003) (1):CD003228
42. Rand T., Basile A., Cejna M., et al. PTA versus carbofilm-coated stents in infrapopliteal arteries: pilot study. Cardiovasc Intervent Radiol 29 (2006) 29-38
43. Schillinger M., Sabeti S., Loewe C., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354 (2006) 1879-1888
44. Sabeti S., Czerwenka-Wenkstetten A., Dick P., et al. Quality of life after balloon angioplasty versus stent implantation in the superficial femoral artery: findings from a randomized controlled trial. J Endovasc Ther 14 (2007) 431-437
45. Verta M.J., Schneider J.R., Alonzo M.J., and Hahn D. Percutaneous Viabahn-assisted subintimal recanalization for severe superficial femoral artery occlusive disease. J Vasc Interv Radiol 19 (2008) 493-849
46. Verta M.J., Schneider J.R., Alonzo M., and Hahn D. Percutaneous viabahn-assisted subintimal recanalization (VASIR) for severe femoropopliteal occlusive disease. Acta Chir Belg 107 (2007) 181-186
47. Kessel D.O., Wijesinghe L.D., Robertson I., et al. Endovascular stent-grafts for superficial femoral artery disease: results of 1-year follow-up. J Vasc Interv Radiol 10 (1999) 289-296
48. Duda S.H., Bosiers M., Lammer J., et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 16 (2005) 331-338
49. Wolf G.L., Wilson S.E., Cross A.P., Deupree R.H., and Stason W.B. Surgery or balloon angioplasty for peripheral vascular disease: a randomized clinical trial. Principal investigators and their Associates of Veterans Administration Cooperative Study Number 199. J Vasc Interv Radiol 4 (1993) 639-648